276 related articles for article (PubMed ID: 32709539)
1. Human epidermal growth factor 2 (HER2) in early stage uterine serous carcinoma: A multi-institutional cohort study.
Erickson BK; Najjar O; Damast S; Blakaj A; Tymon-Rosario J; Shahi M; Santin A; Klein M; Dolan M; Cimino-Mathews A; Buza N; Ferriss JS; Stone RL; Khalifa M; Fader AN
Gynecol Oncol; 2020 Oct; 159(1):17-22. PubMed ID: 32709539
[TBL] [Abstract][Full Text] [Related]
2. A novel model to predict cancer-specific survival in patients with early-stage uterine papillary serous carcinoma (UPSC).
Chen L; Liu X; Li M; Wang S; Zhou H; Liu L; Cheng X
Cancer Med; 2020 Feb; 9(3):988-998. PubMed ID: 31846222
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant chemotherapy versus primary cytoreductive surgery for stage IV uterine serous carcinoma.
Wilkinson-Ryan I; Frolova AI; Liu J; Stewart Massad L; Thaker PH; Powell MA; Mutch DG; Hagemann AR
Int J Gynecol Cancer; 2015 Jan; 25(1):63-8. PubMed ID: 25365590
[TBL] [Abstract][Full Text] [Related]
4. Randomized Phase II Trial of Carboplatin-Paclitaxel Compared with Carboplatin-Paclitaxel-Trastuzumab in Advanced (Stage III-IV) or Recurrent Uterine Serous Carcinomas that Overexpress Her2/Neu (NCT01367002): Updated Overall Survival Analysis.
Fader AN; Roque DM; Siegel E; Buza N; Hui P; Abdelghany O; Chambers S; Secord AA; Havrilesky L; O'Malley DM; Backes FJ; Nevadunsky N; Edraki B; Pikaart D; Lowery W; ElSahwi K; Celano P; Bellone S; Azodi M; Litkouhi B; Ratner E; Silasi DA; Schwartz PE; Santin AD
Clin Cancer Res; 2020 Aug; 26(15):3928-3935. PubMed ID: 32601075
[TBL] [Abstract][Full Text] [Related]
5. Role of Adjuvant Therapy for Stage IA Serous and Clear Cell Uterine Cancer: Is Observation a Valid Strategy?
Velker V; D'Souza D; Prefontaine M; McGee J; Leung E
Int J Gynecol Cancer; 2016 Mar; 26(3):491-6. PubMed ID: 26825823
[TBL] [Abstract][Full Text] [Related]
6. Uterine Papillary Serous Carcinoma: A Single-Institution Review of 62 Cases.
Black C; Feng A; Bittinger S; Quinn M; Neesham D; McNally O
Int J Gynecol Cancer; 2016 Jan; 26(1):133-40. PubMed ID: 26588230
[TBL] [Abstract][Full Text] [Related]
7. Population-based treatment and outcomes of Stage I uterine serous carcinoma.
van der Putten LJ; Hoskins P; Tinker A; Lim P; Aquino-Parsons C; Kwon JS
Gynecol Oncol; 2014 Jan; 132(1):61-4. PubMed ID: 24219983
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors for patients with early-stage uterine serous carcinoma without adjuvant therapy.
Tate K; Yoshida H; Ishikawa M; Uehara T; Ikeda SI; Hiraoka N; Kato T
J Gynecol Oncol; 2018 May; 29(3):e34. PubMed ID: 29533019
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes of adjuvant chemotherapy and vaginal brachytherapy with or without pelvic radiation for surgical stage I-II uterine serous carcinoma.
Robbins JR; Siddiqui MS; Al-Wahab Z; Laser B; Lu M; Ali-Fehmi R; Munkarah A; Elshaikh MA
Eur J Gynaecol Oncol; 2012; 33(5):449-54. PubMed ID: 23185785
[TBL] [Abstract][Full Text] [Related]
10. Survival analysis based on human epidermal growth factor 2 status in stage II-III gastric cancer.
Cho JH; Lim JY; Cho JY
World J Gastroenterol; 2017 Nov; 23(41):7407-7414. PubMed ID: 29151694
[TBL] [Abstract][Full Text] [Related]
11. Impact of Chemotherapy and Radiotherapy on Management of Early Stage Clear Cell and Papillary Serous Carcinoma of the Uterus.
Hong JC; Foote J; Broadwater G; Gaillard S; Havrilesky LJ; Chino JP
Int J Gynecol Cancer; 2017 May; 27(4):720-729. PubMed ID: 28375927
[TBL] [Abstract][Full Text] [Related]
12. Role of surgical staging and adjuvant treatment in uterine serous carcinoma.
Frey MK; Bashir S; Ward NM; Hensel KJ; Caputo TA; Holcomb KM; Baergen R; Gupta D
Eur J Gynaecol Oncol; 2013; 34(5):453-6. PubMed ID: 24475582
[TBL] [Abstract][Full Text] [Related]
13. Comparison of outcomes in early-stage uterine clear cell carcinoma and serous carcinoma.
Zhang M; Yang TJ; Desai NB; DeLair D; Kollmeier MA; Makker V; Leitao MM; Abu-Rustum NR; Alektiar KM
Brachytherapy; 2019; 18(1):38-43. PubMed ID: 30316723
[TBL] [Abstract][Full Text] [Related]
14. Uterine papillary serous carcinoma: patterns of failure and survival.
Wang W; DO V; Hogg R; Wain G; Brand A; Bull C; Stenlake A; Gebski V
Aust N Z J Obstet Gynaecol; 2009 Aug; 49(4):419-25. PubMed ID: 19694700
[TBL] [Abstract][Full Text] [Related]
15. Early-stage Uterine Pure and Mixed Clear Cell Carcinoma: Outcomes and Recurrence With and Without Adjuvant Therapy.
Chang-Halpenny CN; Natarajan S; Hwang-Graziano JM
Am J Clin Oncol; 2018 Apr; 41(4):371-378. PubMed ID: 26950465
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological and prognostic impact of human epidermal growth factor receptor type 2 (HER2) and hormone receptor expression in uterine papillary serous carcinoma.
Togami S; Sasajima Y; Oi T; Ishikawa M; Onda T; Ikeda S; Kato T; Tsuda H; Kasamatsu T
Cancer Sci; 2012 May; 103(5):926-32. PubMed ID: 22329832
[TBL] [Abstract][Full Text] [Related]
17. Analysis of treatment failures and survival of patients with uterine papillary serous carcinoma: a Cooperation Task Force (CTF) Study.
Gadducci A; Cosio S; Landoni F; Maggino T; Zola P; Fuso L; Sartori E
Int J Gynecol Cancer; 2012 Oct; 22(8):1355-60. PubMed ID: 22976496
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of patients with uterine serous carcinoma using the revised FIGO staging system.
Seward S; Ali-Fehmi R; Munkarah AR; Semaan A; Al-Wahab ZR; Elshaikh MA; Cote ML; Morris RT; Bandyopadhyay S
Int J Gynecol Cancer; 2012 Mar; 22(3):452-6. PubMed ID: 22274544
[TBL] [Abstract][Full Text] [Related]
19. Uterine carcinosarcoma and high-risk endometrial carcinomas: a clinicopathological comparison.
Zhang C; Hu W; Jia N; Li Q; Hua K; Tao X; Wang L; Feng W
Int J Gynecol Cancer; 2015 May; 25(4):629-36. PubMed ID: 25633654
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.
Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Mizutoh A; Moriya T; Sonoo H
Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
